raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:91127

Adenovirus infection in immunocompromised patients

Type
Particular clinical situation in a disease or syndrome
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare viral disease characterized by invasive and/or disseminated adenovirus infection in immunocompromised patients, either acquired <i>de novo</i> or arising from reactivation of persistent latent infection. The clinical picture comprises a wide range of manifestations including pneumonia, colitis, hepatitis, hemorrhagic cystitis, tubulointerstitial nephritis, encephalitis, and disseminated disease, among others. Severity varies with age and immune status, and life-threatening courses may occur.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAdenovirus infection in immunocompromised patients
frInfection par l'adénovirus chez des patients immunodéprimés
deAdenovirus-Infektion bei immunsupprimierten Patienten
esInfección por adenovirus en pacientes inmunocomprometidos
itInfezione da adenovirus nei pazienti immunodepressi
nlAdenovirusinfectie bij immunogecompromitteerde patiënten
ptInfeção por adenovirus em pacientes imunocomprometidos
plInfekcja adenowirusowa u pacjentów z upośledzeniem odporności
csInfekce adenoviry u imunokompromitovaných pacientů
ukАденовірусна інфекція у пацієнтів з ослабленим імунітетом
zh免疫力低下病人腺病毒感染
trBağışıklık sistemi baskılanmış hastalarda adenovirüs enfeksiyonu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10B34.0NTBTattributedvalidated
ICD-111D90NTBTattributedvalidated
UMLSC5681468Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 00018 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2003[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card